Drug Trial Radar · NCT01842100
To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy
Last checked: Nov 19, 2026Latest source record: Apr 29, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,193
Actual
Start
Sep 1999
Primary completion
Feb 2006
Study completion Feb 2006
Sponsor
- Lead sponsor
- The University of Hong KongAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 29, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- Female only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Screen-and-treat approach reduces postabortal pelvic inflammatory disease after induced abortion, and at the same time alters women's sexual behavior and prevents further re-infection by sexually transmitted infections when compared to the universal antibiotic prophylaxis strategy.
Conditions
- Induced Abortion
- Postaboral Pelvic Inflammatory Disease
- Sexually Transmitted Infections
Interventions
Universal antibiotic prophylaxisDrug
100 mg twice daily for 7 days starting on the day of induced abortion
Screen-and-treatOther
Specific antibiotic treatment was only given if the women was found to have sexually transmitted infection(s) on screening.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of postabortal inflammatory disease 6 weeks after induced abortion.Time frame: 6 weeks after induced abortion.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Queen Mary Hospital
Hong Kong, Hong Kong, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.